Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Tesmilifene (YMB1002)
Sponsor: YM BioSciences